(redirected from Novo-spiroton)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to Novo-spiroton: Aldactone, spironolactone, Spiractin


one of the spirolactones, a competitive antagonist of aldosterone and a potassium-sparing diuretic; used in treatment of edema, hypokalemia, primary aldosteronism, and (usually in combination with other drugs) hypertension.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.


Aldactone, Novo-Spiroton (CA)

Pharmacologic class: Aldosterone inhibitor

Therapeutic class: Potassium-sparing diuretic

Pregnancy risk category D

FDA Box Warning

• Drug induced tumors in chronic toxicity studies in rats. Use only in conditions listed under "Indications and dosages." Avoid unnecessary use.


Inhibits aldosterone effects in distal renal tubule, promoting sodium and water excretion and potassium retention


Tablets: 25 mg, 50 mg, 100 mg

Indications and dosages

Edema caused by heart failure, hepatic cirrhosis, or nephrotic syndrome

Adults: As sole diuretic, initially 100 mg/day P.O. (range of 25 to 200 mg) in single or divided doses, continued for 5 or more days and then adjusted to optimal therapeutic level

Children: 1 to 3 mg/kg/day P.O. as a single dose or in divided doses

Essential hypertension

Adults: Initially, 50 to 100 mg/day P.O. as a single dose or in divided doses, continued for at least 2 weeks

Children: 1 to 2 mg/kg P.O. b.i.d.


Adults: 25 to 100 mg/day P.O.

Diagnosis and treatment of primary hyperaldosteronism

Adults: For diagnosis, 400 mg/day P.O. for 4 days in short test or for 3 to 4 weeks in long test. Resolution of hypokalemia and hypertension confirm diagnosis of primary hyperaldosteronism. Dosages of 100 to 400 mg/day P.O. may be used as a bridge to surgical therapy; in patients unsuitable for this therapy, lowest effective dosage may be used for long-term maintenance.

Off-label uses

• Acne vulgaris

• Familial male precocious puberty (given with other drugs)

• Premenstrual syndrome


• Anuria, acute renal insufficiency, significant impairment of renal excretory function

• Hyperkalemia


Use cautiously in:

• hepatic dysfunction, diabetes mellitus, fluid and electrolyte imbalances, severe heart failure

• concurrent use of other potassium-sparing diuretics, such as amiloride and triamterene (avoid use)

• concurrent use of potassium supplements (avoid use with serum potassium level greater than 3.5 mEq/L)

• concurrent use of ACE inhibitors and nonsteroidal anti-inflammatory drugs (NSAIDs) (use with extreme caution)

• concurrent use of lithium (generally avoid use)

• elderly or debilitated patients

• pregnant or breastfeeding patients

• children (safety not established).


• Give single daily dose with breakfast. If two daily doses are prescribed, give second dose with food in mid-afternoon.

Adverse reactions

CNS: headache, drowsiness, lethargy, ataxia, confusion

GI: vomiting, diarrhea, cramping, gastritis, GI ulcers, GI bleeding

GU: gynecomastia, irregular menses or amenorrhea, postmenopausal bleeding, erectile dysfunction, breast cancer

Hematologic: agranulocytosis

Metabolic: hyponatremia, hyperchloremic metabolic acidosis, hyperkalemia

Skin: rash, pruritus, hirsutism, drug rash with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson Syndrome, toxic epidermal necrolysis

Other: deepening of voice, drug fever, hypersensitivity (including vasculitis, anaphylactic reactions)


Drug-drug. Angiotensin-converting enzyme inhibitors, NSAIDs, potassium-sparing diuretics, potassium supplements, other potassium-containing drugs: increased risk of hyperkalemia

Anticoagulants, heparin: reduced hypoprothrombinemic effects of these drugs

Digoxin: increased digoxin blood level

Lithium: reduced lithium renal clearance and increased risk of lithium toxicity

Salicylates: decreased diuretic effect

Drug-diagnostic tests. Blood urea nitrogen, potassium: increased levels

Digoxin assays: false digoxin elevation

Granulocytes: decreased count

Drug-food. Potassium-containing salt substitutes, potassium-rich diet: increased risk of hyperkalemia

Drug-herbs. Licorice: potassium loss

Patient monitoring

Monitor electrolyte levels (especially potassium), particularly in patients with severe heart failure. Watch for signs and symptoms of imbalances and metabolic acidosis. Interrupt or discontinue treatment for serum potassium level greater than 5 mEq/L or serum creatinine greater than 4 mg/dl.

• Monitor weight and fluid intake and output. Stay alert for indications of fluid imbalance.

• Monitor CBC with white cell differential.

Patient teaching

• Tell patient to take daily dose with breakfast. If two daily doses are prescribed, advise him to take second dose with food in mid-afternoon.

• Advise patient to restrict intake of high-potassium foods and to avoid licorice and salt substitutes containing potassium.

• Tell male patient drug may cause breast enlargement.

• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, foods, and herbs mentioned above.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved


A diuretic agent that blocks the renal tubular actions of aldosterone. It increases the urinary excretion of sodium and chloride, decreases the excretion of potassium and ammonium, and reduces the titratable acidity of the urine; most effectively used to potentiate the natriuretic action and reduce the potassium excretion produced by other diuretics.
Farlex Partner Medical Dictionary © Farlex 2012


(spī′rə-nō-lăk′tōn, spī-rō′-, spī-rŏn′ə-)
An aldosterone antagonist and antiandrogen, C24H32O4S, that promotes diuresis and is used to treat fluid retention, androgenic syndromes in women, and hypertension.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.


A potassium-sparing diuretic, which inhibits aldosterone, resulting in less sodium retention. See Diuretics, Potassium-sparing diuretic.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.


Diuretic that blocks aldosterone's renal tubular actions and increases urinary excretion of sodium and chloride.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012


A DIURETIC drug that does not lead to loss of potassium from the body. It is an antagonist of the hormone aldosterone. The drug is on the WHO official list. Brand names are Aldactone and Spiroctan.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005


A diuretic agent that blocks the renal tubular actions of aldosterone.
Medical Dictionary for the Dental Professions © Farlex 2012